Cargando…

Multicentre derivation and validation of a prognostic scoring system for mortality assessment in HIV‐infected patients with talaromycosis

BACKGROUND: Although the widespread use of modern antiretroviral therapy (ART) has reduced the incidence of talaromycosis in people living with HIV, mortality remains as high as 20% in this population, even after appropriate antifungal treatment. OBJECTIVES: The objective of our study was to develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Yuanyuan, Zhou, Yihong, Lu, Yanqiu, Chen, Hui, Jiang, Zhongsheng, He, Kaiyin, Tian, Qun, Qin, Yingmei, Rao, Man, Harypursat, Vijay, Li, Huan, Chen, Yaokai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839706/ https://www.ncbi.nlm.nih.gov/pubmed/33141968 http://dx.doi.org/10.1111/myc.13206

Ejemplares similares

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
por: Zhou, Yihong, et al.
Publicado: (2022)

Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study
por: Zhou, Yihong, et al.
Publicado: (2023)

Changes of human immunodeficiency virus (HIV) burden globally and in China over three decades: a secondary analysis of global HIV statistics
por: Lu, Yanqiu, et al.
Publicado: (2022)

Independent Risk Factors for Deaths due to AIDS in Chongqing, China: Does Age Matter?
por: Zhou, Yihong, et al.
Publicado: (2021)

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial
por: Qin, Yuanyuan, et al.
Publicado: (2020)

JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review
por: Harypursat, Vijay, et al.
Publicado: (2020)

A Dual Role of Heme Oxygenase-1 in Tuberculosis
por: Yang, Sen, et al.
Publicado: (2022)

The development and validation of a diagnostic scoring system to differentiate pulmonary tuberculosis from non-tuberculosis pulmonary infections in HIV-infected patients with severe immune suppression
por: Ouyang, Jing, et al.
Publicado: (2021)

P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target
por: Zaongo, Silvere D., et al.
Publicado: (2021)

No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study
por: Huang, Yinqiu, et al.
Publicado: (2022)

Single-Cell Sequencing Facilitates Elucidation of HIV Immunopathogenesis: A Review of Current Literature
por: Zaongo, Silvere D., et al.
Publicado: (2022)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Disseminated talaromycosis in an HIV-infected patient
por: Chang, Chee Yik, et al.
Publicado: (2021)

Rare incidence of non-secretory myeloma with talaromycosis: a case report
por: Qin, Haiting, et al.
Publicado: (2021)

Non-HIV talaromycosis: Radiological and clinical analysis
por: Li, Xinchun, et al.
Publicado: (2020)

Drug-related talaromycosis: A case report
por: Lu, Yongsheng, et al.
Publicado: (2020)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
por: Guo, Pengle, et al.
Publicado: (2022)

Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
por: Zhao, Ting, et al.
Publicado: (2022)

Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis
por: Narayanasamy, Shanti, et al.
Publicado: (2021)

Talaromycosis (Penicilliosis): A Rare, Opportunistic Systemic Fungal Infection
por: Gorai, Surajit, et al.
Publicado: (2019)

Talaromycosis in a Lung Cancer Patient: A Rare Case
por: Ching-López, Rosario, et al.
Publicado: (2020)

Successful treatment of AIDS-associated talaromycosis with low-dose itraconazole
por: Pudjiati, Satiti Retno, et al.
Publicado: (2020)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Colesional cutaneous talaromycosis (penicilliosis) and Kaposi sarcoma in an HIV‐infected patient
por: Lai, Shau‐Kong, et al.
Publicado: (2021)

Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains
por: Peng, Lei, et al.
Publicado: (2022)

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine responders
por: Ouyang, Jing, et al.
Publicado: (2022)

Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review
por: Yan, Jiangyu, et al.
Publicado: (2021)

Influence of HIV infection on cognition and overall intelligence in HIV-infected individuals: advances and perspectives
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient
por: Shi, Jiejun, et al.
Publicado: (2021)

S2.2c Talaromycosis in HIV-negative patients: challenges and counter-measures
por: Cao, Cunwei
Publicado: (2022)

Clinical performance of metagenomic next-generation sequencing for the rapid diagnosis of talaromycosis in HIV-infected patients
por: Mao, Yuhuan, et al.
Publicado: (2022)

Predictive factors of progression to severe COVID-19
por: Zhou, Yi-Hong, et al.
Publicado: (2020)

Metagenomic next-generation sequencing for the early diagnosis of talaromycosis in HIV-uninfected patients: five cases report
por: Chen, Qiuhua, et al.
Publicado: (2021)

Imported Talaromycosis in Oman in Advanced HIV: A Diagnostic Challenge Outside the Endemic Areas
por: Mohsin, Jalila, et al.
Publicado: (2017)

Is stopping secondary prophylaxis safe in HIV‐positive talaromycosis patients? Experience from Myanmar
por: Tun, N, et al.
Publicado: (2020)

Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort
por: Klus, Jonathan, et al.
Publicado: (2021)

Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report
por: Cui, Xiaoya, et al.
Publicado: (2022)

Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV
por: Ouyang, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i5hnraaom6umuh05705uj4ermt